At the top of Jim Cramer's Tuesday night Mad Money program, he pointed out Regeneron Pharmaceuticals (REGN) to viewers. Regeneron rose 6% Tuesday as bioscience continues to power higher on American ingenuity. Let's check the charts of this biotech company that invents life-transforming medicines for people with serious diseases.
More from Investing
In late August/early September the major indices were making medium-term tops.
Sizable, sudden losses will occur when the market turns. Find ways to use that to your advantage.
Depending on how a couple of factors play out, growth rates in areas such as gaming and e-commerce could accelerate further.
Obstacles that lie ahead, but this market never seems to embrace a negative narrative for long.